Joseph France
Stock Analyst at Cantor Fitzgerald
(2.68)
# 1,867
Out of 5,179 analysts
55
Total ratings
65.71%
Success rate
10.74%
Average return
Main Sectors:
Stocks Rated by Joseph France
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $83 → $85 | $22.91 | +271.02% | 7 | Sep 14, 2023 | |
| HCA HCA Healthcare | Maintains: Buy | $285 → $320 | $471.85 | -32.18% | 3 | Apr 24, 2023 | |
| ELV Elevance Health | Maintains: Buy | $565 → $550 | $286.39 | +92.05% | 1 | Apr 21, 2023 | |
| UNH UnitedHealth Group | Maintains: Buy | $590 → $600 | $259.02 | +131.64% | 4 | Apr 17, 2023 | |
| CCRN Cross Country Healthcare | Initiates: Buy | $30 | $9.52 | +215.13% | 9 | Mar 10, 2023 | |
| CVS CVS Health | Initiates: Buy | $120 | $70.08 | +71.23% | 2 | Jun 17, 2022 | |
| THC Tenet Healthcare | Initiates: Buy | $80 | $191.86 | -58.30% | 2 | Jun 17, 2022 | |
| UHS Universal Health Services | Initiates: Hold | $115 | $184.04 | -37.51% | 3 | Jun 17, 2022 | |
| CI The Cigna Group | Initiates: Hold | $270 | $261.96 | +3.07% | 2 | Jun 17, 2022 | |
| MOH Molina Healthcare | Initiates: Hold | $310 | $134.03 | +131.29% | 1 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $5 | $2.86 | +74.83% | 2 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $510 | $169.09 | +201.61% | 3 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $32.00 | +212.50% | 2 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $50 | $200.66 | -75.08% | 3 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $103 → $107 | $74.75 | +43.14% | 3 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $10 | $2.02 | +395.05% | 2 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $95.19 | -19.11% | 1 | Sep 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $46 | $37.24 | +23.52% | 1 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $80 | $82.20 | -2.68% | 1 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $34 | $44.54 | -23.66% | 1 | Dec 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $21 | $16.59 | +26.58% | 1 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $7 | $18.34 | -61.83% | 1 | Jul 6, 2017 |
Acadia Healthcare Company
Sep 14, 2023
Maintains: Neutral
Price Target: $83 → $85
Current: $22.91
Upside: +271.02%
HCA Healthcare
Apr 24, 2023
Maintains: Buy
Price Target: $285 → $320
Current: $471.85
Upside: -32.18%
Elevance Health
Apr 21, 2023
Maintains: Buy
Price Target: $565 → $550
Current: $286.39
Upside: +92.05%
UnitedHealth Group
Apr 17, 2023
Maintains: Buy
Price Target: $590 → $600
Current: $259.02
Upside: +131.64%
Cross Country Healthcare
Mar 10, 2023
Initiates: Buy
Price Target: $30
Current: $9.52
Upside: +215.13%
CVS Health
Jun 17, 2022
Initiates: Buy
Price Target: $120
Current: $70.08
Upside: +71.23%
Tenet Healthcare
Jun 17, 2022
Initiates: Buy
Price Target: $80
Current: $191.86
Upside: -58.30%
Universal Health Services
Jun 17, 2022
Initiates: Hold
Price Target: $115
Current: $184.04
Upside: -37.51%
The Cigna Group
Jun 17, 2022
Initiates: Hold
Price Target: $270
Current: $261.96
Upside: +3.07%
Molina Healthcare
Jun 17, 2022
Initiates: Hold
Price Target: $310
Current: $134.03
Upside: +131.29%
Jun 17, 2022
Initiates: Hold
Price Target: $5
Current: $2.86
Upside: +74.83%
Jun 17, 2022
Initiates: Buy
Price Target: $510
Current: $169.09
Upside: +201.61%
Jun 17, 2022
Initiates: Buy
Price Target: $100
Current: $32.00
Upside: +212.50%
Nov 2, 2018
Maintains: Overweight
Price Target: $42 → $50
Current: $200.66
Upside: -75.08%
Nov 2, 2018
Maintains: Neutral
Price Target: $103 → $107
Current: $74.75
Upside: +43.14%
Sep 28, 2018
Downgrades: Neutral
Price Target: $12 → $10
Current: $2.02
Upside: +395.05%
Sep 13, 2018
Initiates: Overweight
Price Target: $77
Current: $95.19
Upside: -19.11%
Aug 10, 2018
Maintains: Overweight
Price Target: $45 → $46
Current: $37.24
Upside: +23.52%
Aug 8, 2018
Maintains: Neutral
Price Target: $75 → $80
Current: $82.20
Upside: -2.68%
Dec 21, 2017
Initiates: Overweight
Price Target: $34
Current: $44.54
Upside: -23.66%
Nov 7, 2017
Maintains: Overweight
Price Target: $20 → $21
Current: $16.59
Upside: +26.58%
Jul 6, 2017
Initiates: Overweight
Price Target: $7
Current: $18.34
Upside: -61.83%